This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Artesunate 110 mg vials, a critical medication, with a total ceiling value of $6,869.75 and a period of performance through December 23, 2024. The contract has a firm fixed-price pricing type and does not appear to have any set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical commodities.
Generated 3/21/25, 9:49 AM